BibTex RIS Kaynak Göster

Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans'ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması

Yıl 2006, Cilt: 37 Sayı: 2, 37 - 40, 20.07.2014

A.serda Kantarcıoğlu Ayhan Yücel Valerio Vidottto Valerio Vıdotto

Anahtar Kelimeler

Cryptococcus neoformans fenoloksidaz Pal agar

Kaynakça

  • 1. Dromer F, Mathoulin S, DupontB, l..aporteA. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993), French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82-90.
  • 2. PerfectJ, Casadeval A. Cryptococcosis. Infect Dis Clin N Am 2002; 16: 837-874.
  • 3. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Tracie G, Sattah M, Ponce de Leon G, Baughman W, Hajjeh RA. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-794.
  • 4. Viviani MA, Swinne D, Kouzmanov A, Dromer F, lintelnot K, Lemmer K, Velegraki A, Radlca N, Polacheck I, Antinori S, Cogliati M, Esposto C, Nowiclca J, Velho R, Vasilyeva N, Colom Valiente F, Petrini B, Polak AM, Schar G, Hoepelman H, Johnson E. Survey of cryptocoocosis in Europe: the ECMM Working Group report. Abstracts of 6th ECMM Congress, Barcelona, 9-11 November, 2000.
  • 5. Viviani M. Epidemiological survey of cryptococcosis in Europe. Mycology Newsletter, February 2003: 6-7.
  • 6. Van Elden U, Walenkamp AM, LipovskY MM, Reiss P, Meis JF, DE Marie S, DankertJ, Hoepelman AL. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 2000; 14: 2787-2788.
  • 7. Tintelnot K, Schar G, Polak A. Epidemiological data of cryptoc:occosis in Austria, Germany and Swizerland: part of ECMM survey in Europe. Mycoses 2001; 44: 345-350.
  • 8. Kantarcioglu S, Yucel A. Epidemiology of human cryptococcosis in Turkey in 1953-2003. In: Trends in Medical Myrology. Bologna, Monduzzi Editore, 2003: 59-66.
  • 9. AbergJA, MundyLM, PowderlyWG. Pulmonarycryptococcosis in patients without HIV infection. Chest 1999; 115: 734-740.
  • 10. NunezM, PeacockJE, Chin R. Pulmonarycryptococcosis in the immunocompetent host. Chest 2000; 118: 527-534.
  • 11. Staib F, Seibold M, Antweiler E, Frolich B, Weber S, Blisse A. The brown color effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentbl Bakteriol Microbial Hyg 1987; 266: 167-177.
  • 12. Pal M, Onda C, Hasegawa A. Isolation of saprophytic Cryptococcus neoformans. Jpn J Vet. Sci 1990; 52: 1171-1174.
  • 13. Pal M. Pulmonary mycosis in a pigeon handler due to Cryptococcus neoformans var. neoformans. 2nd International Conference on Cryptococcus and cryptococcosis. Milan (Italy), 1993. Abstracts, pp. 4-5, p. 119.
  • 14. Yucel A, Kantarc1oglu AS. Dogadan ay1rd1g1m1z dort Cryptococcus neoformans kokeni ve bu mantarm ekolojisinde bitkinin yeri. infeksiyon Derg 2001; 2: 205-214.
  • 15. Chaskes S, Tyndall RL. Pigment production by Cryptococcus neoformans from para and ortho-diphenols: effect of the nitrogen source. J Clin Microbiol 1975; 1: 509-514. 40
  • 16. Pulverer C, Korth H. Cryptococcus neoformans: Pigmentbildung aus verschiedenen Polyphenolen. Med Microbial lmmunol 1971; 175: 46-51.
  • 17. Shaw CE, Kapica L. Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl Microbiol 1972; 24: 824-830.
  • 18. Chaskes S, Tyndall RL. Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes. J Clin Microbiol 1978; 7: 146-152.
  • 19. Sasaki K, Matsusaka N, Sato I, Tsuda S, Tsutsumi K, Ito K, Hasegawa A, Pal M. Isolation of Cryptococcus neoformans from pigeon excreta. J Jpn Vet Med Assoc 1999; 52: 521-524.
  • 20. Pal M. First report of Cryptococcus neoformans var. neoformans from avian excreta in Kathmandu, Nepal. Rev Ibero Am Mycol 1997; 14: 181-183.
  • 21. Douchet C, Chandenier J, Barrabes A, Therizol-Ferly M, Richard-Lenoble D. Reconnaissance rapide de colonies de Cryptococcus neoformans par une methode simple. J Mycol Med 1995; 5: 122-123.
  • 22. Kantarc1ogl u, A.S. ve A.Yilcel, "Epidemiology of human cryptococcosis in Turkey (1953-2003)", Proceedings ofTrends in Medical Mycology (September 28-0ctober 1, 2003, Amsterdam, The Netherlands) Milano, 59- 66, Monduzzi Editore 2003.
  • 23. Kantarc1oglu AS, Gilleni; M, Yilcel A, Uzun N, Ta§km T, Sak1z D, Alta§ K. Cryptococcal parotid involvement: an uncommon localization of Cryptococcus neoformans. Report of a case. Med Mycol (bask1da).
  • 24. Al Mosaid A, Sullivan DJ, Coleman DC. Differentiation of of Candida dubliniensis from Candida albicans on Pal's agar. J Clin Microbiol 2003; 41: 4787-4789.

Yıl 2006, Cilt: 37 Sayı: 2, 37 - 40, 20.07.2014

A.serda Kantarcıoğlu Ayhan Yücel Valerio Vidottto Valerio Vıdotto

Kaynakça

  • 1. Dromer F, Mathoulin S, DupontB, l..aporteA. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993), French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82-90.
  • 2. PerfectJ, Casadeval A. Cryptococcosis. Infect Dis Clin N Am 2002; 16: 837-874.
  • 3. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Tracie G, Sattah M, Ponce de Leon G, Baughman W, Hajjeh RA. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-794.
  • 4. Viviani MA, Swinne D, Kouzmanov A, Dromer F, lintelnot K, Lemmer K, Velegraki A, Radlca N, Polacheck I, Antinori S, Cogliati M, Esposto C, Nowiclca J, Velho R, Vasilyeva N, Colom Valiente F, Petrini B, Polak AM, Schar G, Hoepelman H, Johnson E. Survey of cryptocoocosis in Europe: the ECMM Working Group report. Abstracts of 6th ECMM Congress, Barcelona, 9-11 November, 2000.
  • 5. Viviani M. Epidemiological survey of cryptococcosis in Europe. Mycology Newsletter, February 2003: 6-7.
  • 6. Van Elden U, Walenkamp AM, LipovskY MM, Reiss P, Meis JF, DE Marie S, DankertJ, Hoepelman AL. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 2000; 14: 2787-2788.
  • 7. Tintelnot K, Schar G, Polak A. Epidemiological data of cryptoc:occosis in Austria, Germany and Swizerland: part of ECMM survey in Europe. Mycoses 2001; 44: 345-350.
  • 8. Kantarcioglu S, Yucel A. Epidemiology of human cryptococcosis in Turkey in 1953-2003. In: Trends in Medical Myrology. Bologna, Monduzzi Editore, 2003: 59-66.
  • 9. AbergJA, MundyLM, PowderlyWG. Pulmonarycryptococcosis in patients without HIV infection. Chest 1999; 115: 734-740.
  • 10. NunezM, PeacockJE, Chin R. Pulmonarycryptococcosis in the immunocompetent host. Chest 2000; 118: 527-534.
  • 11. Staib F, Seibold M, Antweiler E, Frolich B, Weber S, Blisse A. The brown color effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentbl Bakteriol Microbial Hyg 1987; 266: 167-177.
  • 12. Pal M, Onda C, Hasegawa A. Isolation of saprophytic Cryptococcus neoformans. Jpn J Vet. Sci 1990; 52: 1171-1174.
  • 13. Pal M. Pulmonary mycosis in a pigeon handler due to Cryptococcus neoformans var. neoformans. 2nd International Conference on Cryptococcus and cryptococcosis. Milan (Italy), 1993. Abstracts, pp. 4-5, p. 119.
  • 14. Yucel A, Kantarc1oglu AS. Dogadan ay1rd1g1m1z dort Cryptococcus neoformans kokeni ve bu mantarm ekolojisinde bitkinin yeri. infeksiyon Derg 2001; 2: 205-214.
  • 15. Chaskes S, Tyndall RL. Pigment production by Cryptococcus neoformans from para and ortho-diphenols: effect of the nitrogen source. J Clin Microbiol 1975; 1: 509-514. 40
  • 16. Pulverer C, Korth H. Cryptococcus neoformans: Pigmentbildung aus verschiedenen Polyphenolen. Med Microbial lmmunol 1971; 175: 46-51.
  • 17. Shaw CE, Kapica L. Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl Microbiol 1972; 24: 824-830.
  • 18. Chaskes S, Tyndall RL. Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes. J Clin Microbiol 1978; 7: 146-152.
  • 19. Sasaki K, Matsusaka N, Sato I, Tsuda S, Tsutsumi K, Ito K, Hasegawa A, Pal M. Isolation of Cryptococcus neoformans from pigeon excreta. J Jpn Vet Med Assoc 1999; 52: 521-524.
  • 20. Pal M. First report of Cryptococcus neoformans var. neoformans from avian excreta in Kathmandu, Nepal. Rev Ibero Am Mycol 1997; 14: 181-183.
  • 21. Douchet C, Chandenier J, Barrabes A, Therizol-Ferly M, Richard-Lenoble D. Reconnaissance rapide de colonies de Cryptococcus neoformans par une methode simple. J Mycol Med 1995; 5: 122-123.
  • 22. Kantarc1ogl u, A.S. ve A.Yilcel, "Epidemiology of human cryptococcosis in Turkey (1953-2003)", Proceedings ofTrends in Medical Mycology (September 28-0ctober 1, 2003, Amsterdam, The Netherlands) Milano, 59- 66, Monduzzi Editore 2003.
  • 23. Kantarc1oglu AS, Gilleni; M, Yilcel A, Uzun N, Ta§km T, Sak1z D, Alta§ K. Cryptococcal parotid involvement: an uncommon localization of Cryptococcus neoformans. Report of a case. Med Mycol (bask1da).
  • 24. Al Mosaid A, Sullivan DJ, Coleman DC. Differentiation of of Candida dubliniensis from Candida albicans on Pal's agar. J Clin Microbiol 2003; 41: 4787-4789.
Toplam 24 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırmalar
Yazarlar

A.serda Kantarcıoğlu Bu kişi benim

Ayhan Yücel Bu kişi benim

Valerio Vidottto Bu kişi benim

Valerio Vıdotto Bu kişi benim

Yayımlanma Tarihi 20 Temmuz 2014
Yayımlandığı Sayı Yıl 2006 Cilt: 37 Sayı: 2

Kaynak Göster

APA Kantarcıoğlu, A., Yücel, A., Vidottto, V., Vıdotto, V. (2014). Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi, 37(2), 37-40.
AMA Kantarcıoğlu A, Yücel A, Vidottto V, Vıdotto V. Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi. Temmuz 2014;37(2):37-40.
Chicago Kantarcıoğlu, A.serda, Ayhan Yücel, Valerio Vidottto, ve Valerio Vıdotto. “Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi Ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar Ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması”. Cerrahpaşa Tıp Dergisi 37, sy. 2 (Temmuz 2014): 37-40.
EndNote Kantarcıoğlu A, Yücel A, Vidottto V, Vıdotto V (01 Temmuz 2014) Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi 37 2 37–40.
IEEE A. Kantarcıoğlu, A. Yücel, V. Vidottto, ve V. Vıdotto, “Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması”, Cerrahpaşa Tıp Dergisi, c. 37, sy. 2, ss. 37–40, 2014.
ISNAD Kantarcıoğlu, A.serda vd. “Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi Ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar Ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması”. Cerrahpaşa Tıp Dergisi 37/2 (Temmuz 2014), 37-40.
JAMA Kantarcıoğlu A, Yücel A, Vidottto V, Vıdotto V. Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi. 2014;37:37–40.
MLA Kantarcıoğlu, A.serda vd. “Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi Ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar Ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması”. Cerrahpaşa Tıp Dergisi, c. 37, sy. 2, 2014, ss. 37-40.
Vancouver Kantarcıoğlu A, Yücel A, Vidottto V, Vıdotto V. Cryptococcus Neoformans Kökenlerinin İn Vitro Fenol Oksidaz Etkinliğinin Belirlenmesi ve C. Neoformans’ın Candida Albicans Kolonilerinden Ayırdedilmesi İçin Pal Ağar ve Niger Seed Ağar Besiyerlerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi. 2014;37(2):37-40.